- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05012046
Effect of 100% Orange Juice on Food Intake and Glycemic Response in Adults
March 2, 2023 updated by: Nick Bellissimo, Ryerson University
Effect of 100% Orange Juice Intake on Subjective Appetite, Food Intake, Glycemic Response and Subjective Mood in Healthy Adults
The purpose of this study is to determine the effects of 100% orange juice on short-term food intake (FI), satiety, post-prandial glycemia and mood in healthy adults.
We hypothesize that the consumption of 100% orange juice in the pre-meal environment will improve satiety signals and mood, and suppress FI through its effect on post-prandial glycemia.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A randomized within-subjects repeated measures design will be employed.
Study visits will take place in the morning, separated one-week apart.
At each session, participants will consume one of three treatments: 1) 100% orange juice; 2) orange flavoured drink; or 3) water.
Glycemic response will be measured for 60 minutes (baseline (0 minutes), 15 minutes, 30 minutes, 45 minutes and 60 minutes) post-treatment via finger prick.
Blood glucose measures will also be provided over 24 hours via a Dexcom G6 continuous glucose monitoring (CGM) device.
Subjective appetite, emotions and mood will be measured for 90 minutes min (baseline (0 minutes), 15 minutes, 30 minutes, 45 minutes, 60 minutes and 90 minutes) post-treatment.
At 60 minutes, participants will consume an ad libitum pizza lunch to evaluate food intake.
After lunch, participants will be sent home with a rest-of-the-day food intake sheet to record their snacks, meals, and beverages, as well as a physical activity log to record their physical activity for the rest of the day following test session completion.
Study Type
Interventional
Enrollment (Actual)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5B 2K3
- Centre for Urban Innovation (CUI-109), School of Nutrition, Ryerson University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- aged 18-45 years;
- within the healthy body mass index (BMI) range for adults of 18.5-24.9 kg/m2.
Exclusion Criteria:
- individuals who are dieting;
- restrained eaters;
- breakfast skippers;
- those who dislike breakfast or lunch treatment foods;
- those taking medication;
- individuals with any metabolic disorders or significant weight fluctuations.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Orange juice
Treatment beverage
|
Matched for volume (240 mL/ 8 oz) of other test beverages.
100% orange juice.
|
|
Experimental: Orange flavoured drink
Treatment beverage
|
Matched for volume (240 mL/ 8 oz) of other test beverages.
Orange flavoured drink
|
|
Experimental: Water
Treatment beverage
|
Matched for volume (240 mL/ 8 oz) of other test beverages.
Water control
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline glycemic response (acute phase)
Time Frame: Collected at baseline (0 minutes), 15 minutes, 30 minutes, 45 minutes, and 60 minutes post-treatment consumption
|
Blood glucose (mmol/L).
Three drops of blood from the finger will be collected at each time point using a single-use, auto-disabling lancet device and sodium fluoride/potassium oxalate capillary blood collection tubes.
Blood glucose will be measured using a YSI 2900D Biochemistry Analyzer (YSI Inc., Yellow Springs, OH).
|
Collected at baseline (0 minutes), 15 minutes, 30 minutes, 45 minutes, and 60 minutes post-treatment consumption
|
|
Rest-of-day blood glucose concentrations
Time Frame: Continuous measurements for 24 hours post-treatment consumption
|
Blood glucose (mmol/L).
Rest-of-day blood glucose concentrations will be determined using a Dexcom G6 CGM system.
|
Continuous measurements for 24 hours post-treatment consumption
|
|
Ad libitum food intake
Time Frame: At 60 minutes post-treatment consumption
|
Lunch pizza meal.
Food intake will be determined by weighing the meal before and after serving.
The net weight of the test meal will be converted to calories.
|
At 60 minutes post-treatment consumption
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline subjective appetite
Time Frame: Collected at baseline (0 minutes), 15 minutes, 30 minutes, 45 minutes, and 60 minutes post-treatment consumption
|
Measured using visual analogue scales (VAS).
Each VAS is a 100 mm line where they will place a pencil mark to describe their feelings.
Questions will include desire to eat, fullness, hunger, and prospective food consumption.
Individual questions will be used to form a composite score.
|
Collected at baseline (0 minutes), 15 minutes, 30 minutes, 45 minutes, and 60 minutes post-treatment consumption
|
|
Change from baseline subjective emotions and mood
Time Frame: Collected at baseline (0 minutes), 15 minutes, 30 minutes, 45 minutes, and 60 minutes post-treatment consumption
|
Measured using visual analogue scales.
Each VAS is a 100 mm line where they will place a pencil mark to describe their feelings.
Questions will measure aggression, anger, excitement, disappointment, frustration, alertness, sadness, tension, effort, happiness, weariness, calmness, sleepiness, and wellness.
Individual questions will be used to form a composite score.
|
Collected at baseline (0 minutes), 15 minutes, 30 minutes, 45 minutes, and 60 minutes post-treatment consumption
|
|
Rest-of-the-day food intake
Time Frame: For the rest of the day following test session completion (1 day)
|
Participants will be sent home with a rest-of-the-day food intake recall sheet to record their snacks, meals, and beverages. Rest of day food log |
For the rest of the day following test session completion (1 day)
|
|
Rest-of-the-day physical activity
Time Frame: For the rest of the day following test session completion (1 day)
|
Participants will be sent home with a rest-of-the-day physical activity recall sheet to record any activities performed. Physical activity questionnaire |
For the rest of the day following test session completion (1 day)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2021
Primary Completion (Actual)
December 22, 2022
Study Completion (Actual)
December 22, 2022
Study Registration Dates
First Submitted
August 11, 2021
First Submitted That Met QC Criteria
August 17, 2021
First Posted (Actual)
August 19, 2021
Study Record Updates
Last Update Posted (Estimate)
March 6, 2023
Last Update Submitted That Met QC Criteria
March 2, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- REB: 2021-177
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
University of Vermont Medical CenterAvocado Nutrition CenterRecruitingHealthy | Healthy Volunteers | Healthy Subjects | Healthy Volunteer | Healthy Adult | Healthy Volunteers Only | Healthy Male and Female Subjects | Healthy Non-smokersUnited States
-
Dragonfly TherapeuticsRecruitingHealthy | Healthy Participants | Healthy Adult Females | Volunteer | Healthy Adult MaleAustralia
-
Umm Al-Qura UniversityActive, not recruitingHealthy | Healthy Participants | Healthy Adult | Healthy Women | Healthy Adult Females | Healthy Adult Participants | Healthy Young Adults | Healthy Adult Female Participants | Healthy Adult Male | Poor Sleep Quality | Healthy (Controls) | Poor Sleeping Quality | Healthy Adult Male Subjects | Health Adult SubjectsSaudi Arabia
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
University of PalermoCompletedHealthy Participants | Healthy Adult Participants | Healthy Young AdultsItaly
-
University of PalermoCompletedHealthy | Healthy Volunteers | Healthy Subjects | Healthy Participants | Static Stretching | Stretch | StretchingItaly
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
PfizerNot yet recruitingHealthy | Healthy AdultsUnited States
-
Atisama TherapeuticsRecruitingHealthy | Healthy SmokerAustralia
Clinical Trials on Orange juice
-
María-Teresa García-ConesaUniversidad Católica San Antonio de MurciaCompleted
-
PepsiCo Global R&DCompletedDigestive HealthUnited States
-
PepsiCo Global R&DCompletedGlycemic ResponseUnited States
-
Loma Linda UniversityCompletedBlood PressureUnited States
-
University of ReadingCompleted
-
Quadram Institute BioscienceBiotechnology and Biological Sciences Research Council; European CommissionCompleted
-
Hasselt UniversityHochschule Geisenheim UniversityCompleted
-
TNOCompletedInflammation | Alcohol ConsumptionNetherlands
-
Rutgers, The State University of New JerseyCompleted
-
University of HohenheimCompleted